- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2021-002491-39.
Displaying page 1 of 1.
EudraCT Number: 2021-002491-39 | Sponsor Protocol Number: SGNTUC-028 | Start Date*: 2022-02-11 | |||||||||||||||||||||
Sponsor Name:Seagen Inc. | |||||||||||||||||||||||
Full Title: A randomized, double-blind, phase 3 study of tucatinib or placebo in combination with trastuzumab and pertuzumab as maintenance therapy for metastatic HER2+ breast cancer (HER2CLIMB-05) | |||||||||||||||||||||||
Medical condition: Unresectable locally-advanced or metastatic HER2+ breast cancer | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FR (Ongoing) PT (Trial now transitioned) ES (Ongoing) PL (Ongoing) IT (Ongoing) AT (Ongoing) GR (Ongoing) CZ (Trial now transitioned) FI (Trial now transitioned) NL (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.